Journal ArticleDOI
Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
TLDR
LncRNAs are emerging as convenient and minimally invasive diagnostic/prognostic markers, and also as therapeutic target for the selective killing of cancer cells in patients.Abstract:
Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non-coding RNAs (lncRNAs) in cancer patients continues to increase. LncRNAs have shown potential as a biomarker in the diagnosis and prognosis of bladder cancer, prostate cancer, gastric cancer, pancreatic cancer, breast cancer and many other cancer types. Some lncRNAs have also been used as adjunct to improve the specificity and sensitivity of existing biomarkers. The molecular tools such as RNA-seq, RNA-FISH, ic-SHAPE and quantitative real-time PCR have been used for examining the lncRNAs' potential. Some lncRNAs such as PCA3 is now routinely used in the clinic for the diagnosis of prostate cancer. Single nucleotide polymorphisms (SNPs) in lncRNAs can also be used as a predictor of cancer risk. Although ongoing studies continue to unravel the underlying mechanism, some lncRNAs have been used as therapeutic targets for the selective killing of cancer cells in patients. Thus lncRNAs are emerging as convenient and minimally invasive diagnostic/prognostic markers, and also as therapeutic target. Companies such as the Curna Inc., MiNA Therapeutics Ltd. and RaNA Therapeutics Inc. have been taking steps to develop lncRNA based strategies against cancer. In this review, we discuss the potential of lncRNAs as biomarkers and therapeutic targets in cancer patients.read more
Citations
More filters
Journal ArticleDOI
Biomarkers of gastric cancer: Current topics and future perspective.
Tasuku Matsuoka,Masakazu Yashiro +1 more
TL;DR: The current status and approaches in GC biomarker are summarized, which could be potentially used for early diagnosis, accurate prediction of therapeutic approaches and the future perspective based on the molecular classification and profiling is discussed.
Journal ArticleDOI
LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer
Gang Zhang,Shuwei Li,Jiafei Lu,Yuqiu Ge,Qiaoyan Wang,Gaoxiang Ma,Qinghong Zhao,Dongdong Wu,Weida Gong,Mulong Du,Haiyan Chu,Meilin Wang,Aihua Zhang,Zhengdong Zhang +13 more
TL;DR: MT1JP, a down-regulated lncRNA in GC, was associated with malignant tumor phenotypes and survival of GC, and it is suggested that MT1JP may act as a potential therapeutic target and prognosis biomarker for GC.
Journal ArticleDOI
Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.
Shruti Mishra,Sumit Singh Verma,Vipin Rai,Nikee Awasthee,Srinivas Chava,Kam M. Hui,Alan Prem Kumar,Kishore B. Challagundla,Gautam Sethi,Subash C. Gupta +9 more
TL;DR: How the modulation of lncRNAs by phytochemicals produce therapeutic effects on cancer and other chronic diseases is discussed in this review.
Journal ArticleDOI
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.
Nicola Amodio,Maria Angelica Stamato,Giada Juli,Eugenio Morelli,Mariateresa Fulciniti,Martina Manzoni,Martina Manzoni,Elisa Taiana,Elisa Taiana,Luca Agnelli,Luca Agnelli,Maria Eugenia Gallo Cantafio,Enrica Romeo,Lavinia Raimondi,Daniele Caracciolo,Valeria Zuccalà,Marco Rossi,Antonino Neri,Antonino Neri,Nikhil C. Munshi,Nikhil C. Munshi,Pierosandro Tagliaferri,Pierfrancesco Tassone,Pierfrancesco Tassone +23 more
TL;DR: A crucial role of MALAT1 in the regulation of the proteasome machinery is demonstrated, and proof-of-concept that its targeting is a novel powerful option for the treatment of MM is provided.
Journal ArticleDOI
Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors.
Peixin Dong,Ying Xiong,Junming Yue,Sharon J.B. Hanley,Noriko Kobayashi,Yukiharu Todo,Hidemichi Watari +6 more
TL;DR: The latest insights into the expression pattern, biological roles and mechanisms underlying the function and regulation of NEAT1 in tumors are highlighted, and its clinical implication as a new diagnostic biomarker and an attractive therapeutic target for cancers is focused on.
References
More filters
Journal ArticleDOI
PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome
Ina L. Deras,Sheila M.J. Aubin,Amy Blase,John R. Day,Seongjoon Koo,Alan W. Partin,William J. Ellis,Leonard S. Marks,Yves Fradet,Harry G. Rittenhouse,Jack Groskopf +10 more
TL;DR: PCA3 is independent of prostate volume, serum prostate specific antigen level and the number of prior biopsies and logistic regression results suggest that the PCA3 score could be incorporated into a nomogram for improved prediction of biopsy outcome.
Journal ArticleDOI
Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish
An Xiao,Zhanxiang Wang,Yingying Hu,Yingdan Wu,Zhou Luo,Zhipeng Yang,Yao Zu,Wenyuan Li,Peng Huang,Xiangjun Tong,Zuoyan Zhu,Shuo Lin,Bo Zhang +12 more
TL;DR: These findings indicate that both TALENs and Cas9/gRNAs can be used as an efficient tool to engineer genomes to achieve large deletions or inversions, including fragments covering multiple genes and non-coding sequences.
Journal ArticleDOI
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
Leonard S. Marks,Yves Fradet,Ina L. Deras,Amy Blase,Jeannette Mathis,Sheila M.J. Aubin,Anthony T. Cancio,Marie Desaulniers,William J. Ellis,Harry G. Rittenhouse,Jack Groskopf +10 more
TL;DR: In men undergoing repeat prostate biopsy to rule out cancer, the urinary PCA3 score was superior to serum PSA determination for predicting the biopsy outcome, suggesting that thePCA3 assay could have an important role in prostate cancer diagnosis.
Journal ArticleDOI
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
Harry R. Büller,Claudette Bethune,Sanjay Bhanot,David Gailani,Brett P. Monia,Gary E. Raskob,Annelise Segers,Peter Verhamme,Jeffrey I. Weitz +8 more
TL;DR: This study showed that factor XI contributes to postoperative venous thromboembolism; reducing factor XI levels in patients undergoing elective primary unilateral total knee arthroplasty was an effective method for its prevention and appeared to be safe with respect to the risk of bleeding.
Journal ArticleDOI
Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma.
Xiaosong Wang,Zheng Zhang,Hong Cheng Wang,Jian Liang Cai,Qingwen Xu,Meng Qiang Li,Yi Cheng Chen,Xiao Ping Qian,Tian Jing Lu,Li Zhang Yu,Yu Zhang,Dian Qi Xin,Yan Qun Na,Wei Feng Chen +13 more
TL;DR: UCA1 was identified as a novel noncoding RNA gene dramatically up-regulated in TCC and it is the most TCC-specific gene yet identified, which could have important implications in postoperative noninvasive follow-up.